Enoxaparin sodium is a low molecular weight heparin marketed under the trade names ROLEXAN, among others. It is an anticoagulant used to prevent deep vein thrombosis (DVT) or to treat acute deep vein thrombosis with or without pulmonary embolism (PE). It is given as an injection just under the skin or intravenously. Its use is evolving in acute coronary syndromes (ACS).
Enoxaparin is available from its originator as well as generic companies.
It is on the WHO Model List of Essential Medicines, the most important medications needed in a basic health system